搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 天
AAD awarded BARDA contract to develop next gen CBC, sepsis diagnostic system
Ad Astra Diagnostics (AAD), developer of rapid diagnostic and data systems, today announced that it has been awarded a ...
1 天
Edmonton MedTech Start-Up MACH32 Awarded Research and Development Contract From BARDA To ...
MACH32 announced today that it has been awarded an EZ-BAA Advanced Research and Development contract from Biomedical Advanced ...
BioWorld
3 天
Grifols partners with BARDA to test ocular immunoglobulin for sulfur mustard-induced eye damage
Grifols SA has entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to ...
3 天
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as ...
Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from ...
3 天
Grifols partners with BARDA for PoC testing of ocular immunoglobulin
Grifols (GRFS) has established a partnership with the Biomedical Advanced Research and Development Authority to test investigational ocular ...
360dx
1 天
Ad Astra Diagnostics Receives $5M BARDA Contract to Develop Point-of-Care CBC System
The firm's QScout CBC diagnostic system is intended to deliver faster complete blood count test results and detect severe infection earlier.
FiercePharma
11 小时
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
pharmaphorum
2 天
BARDA backs Locus phage therapy for resistant E coli
The payment is part of an $85 million award from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development of LBP-EC01, which has already shown promise in ...
1 天
New $8M grant brings WFIRM's funding for miniaturized organs to over $138M
With an initial funding of $18 million, the eight-year grant will allow WFIRM to study treatments for scar-causing injuries ...
3 天
盖立复与BARDA合作开发芥子气眼部损伤治疗药物
巴塞罗那 - 全球医疗保健公司盖立复(MCE:GRF, MCE:GRF.P, NASDAQ:GRFS)宣布与生物医学高级研究和开发局(BARDA)合作,评估一种用于治疗芥子气导致眼部损伤的实验性眼药水。此次合作旨在探索目前正在开发用于干眼症(DED)的眼表免疫球蛋白(OSIG)眼药水,在中和这种化学战剂影响方面的潜力。 芥子气(俗称芥子气)会导致严重的眼部损伤,可能导致失明。临床前研究将重点关注O ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈